Skip to content

Observation on the quality of life of chronic hepatitis B treated with acupoint magnetotherapy combined with Chinese Medicine

Observation on the quality of life of chronic hepatitis B treated with acupoint magnetotherapy combined with Chinese Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011962
Enrollment
Unknown
Registered
2017-07-12
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Treatment group 1:Ear acupoint magnetotherapy + drug base therapy
Treatment group 2:Traditional Chinese medicine combined with herbal medicine
Treatment group 3:Ear acupoint magnetotherapy + Chinese medicine combined with herbal medicine
control group:Drug based therapy

Sponsors

Infectious Disease Hospital of Shanghai Pudong District of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) accord with the diagnostic standard of chronic hepatitis B; (2) learn more than G2 HBsAg, or HBVDNA positive liver tissue; (3) ALT was more than 2 times the normal value.

Exclusion criteria

Exclusion criteria: (1) hepatitis associated with other hepatitis B virus infections; (2) chronic severe hepatitis and cirrhosis; (3) accompanied by heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal serious primary disease; or mental patients; (4) pregnant women or lactating women; (5) allergic constitution or many kinds of medicine allergy patient.

Design outcomes

Primary

MeasureTime frame
Symptoms of Chinese Medicine;SF-36 concise health scale;Pittsburgh Sleep Scale;Liver function test;

Secondary

MeasureTime frame
Coagulation Function;Routine blood test;

Countries

China

Contacts

Public ContactJianhua Xue

Infectious Disease Hospital of Shanghai Pudong District of Shanghai

61512641@qq.com+86 13585980751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026